Exclusion Criteria:~1. A current clinical condition or requires a medication that raises the pH of their
urine.~2. Severe renal or hepatic impairment.~3. Any other abnormality that could cause a possible cognitive
deficit (including, but not limited to, vascular encephalopathy or large strokes).~4. Contraindications for MRI
(e.g., prostheses, implants, claustrophobia, pacemaker) or PET imaging.~5. Neurodegenerative disorder known to
cause neurocognitive decline~6. Relevant history of or current neurological disease other than preclinical AD,
which may make interpretation of possible new neurological signs or symptoms difficult.~7. Clinically
significant and active pulmonary, gastrointestinal, renal, hepatic, endocrine, or cardiovascular system
disease~8. Ongoing cancer treatment~9. Clinically significant and active psychiatric disorder~10. Use of an
investigational medical device within 3 months before the planned start of study.~11. Current participation in
an interventional study with an investigational drug component.~12. Major surgery (e.g., requiring general
anesthesia) within 8 weeks before screening, or will not have fully recovered from surgery, or has major
surgery planned during the time the subject is expected to participate in the study.~13. Requires treatment
with an AChE inhibitor or any of the following: acetazolamide, methazolamide, amantadine, ketamine,
dextromethorphan.
